CBIO momo uptrend FDA news coming

NASDAQ:CBIO   Catalyst Biosciences, Inc
short term target on chart

see some MOMO until FDA news coming out

Phase 2 commencement of Part 2 of Phase 2/3 trial announced January 4, 2018. Interim data due at ISTH July 18, 2018. Final data due at ASH 2018.

potential gapper candidate
Trade closed: target reached